Filing Details
- Accession Number:
- 0001209191-22-061485
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2022-12-15 17:23:46
- Reporting Period:
- 2022-12-09
- Accepted Time:
- 2022-12-15 17:23:46
- Original Submission Date:
- 2022-12-14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 921299 | Fibrogen Inc | FGEN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1879223 | Juan Graham | C/O Fibrogen, Inc. 409 Illinois Street San Francisco CA 94158 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-12-09 | 781 | $14.89 | 49,369 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-12-12 | 1,407 | $14.50 | 47,962 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.
- These shares were sold in multiple transactions on the reported date with prices ranging from $14.667 to $14.8936 resulting in a weighted average price of $14.89. Upon request, the reporting person will provide to the Commission staff or a security holder of the Issuer the number of sharessold and the sale price for each separate transaction.
- Shares sold pursuant to a 10b5-1 plan.
Billionaire Hedge Funds
